Table 3 |
|||
|
Shared pathways |
|||
|
1 |
(LDL) pathway during atherogenesis 1 |
19 |
IL-2 signaling |
|
2 |
ATM signaling |
20 |
IL-10 anti-inflammatory signaling |
|
3 |
Axon guidance |
21 |
IL-2 receptor beta chain T cell activation |
|
4 |
B cell receptor signaling |
22 |
Keratinocyte differentiation |
|
5 |
Calcium signaling |
23 |
Leukocyte transendothelial migration |
|
6 |
Cell adhesion molecules (CAMs) |
24 |
Long-term depression |
|
7 |
Cell cycle |
25 |
Long-term potentiation |
|
8 |
Colorectal cancer |
26 |
Natural killer cell cytotoxicity |
|
9 |
Complement and coagulation cascades |
27 |
Oxidative stress via Nrf2 |
|
10 |
Control by vitamin D receptor |
28 |
PDGF signaling |
|
11 |
EGF signaling |
29 |
Pertussis toxin-insensitive CCR5 signaling Macrophage |
|
12 |
Epithelial cell signaling H. pylori infection |
30 |
T cell receptor signaling |
|
13 |
FAS signaling (CD95) |
31 |
TGF-beta signaling |
|
14 |
Fc epsilon RI signaling |
32 |
Tight junction |
|
15 |
Focal adhesion |
33 |
Toll-like receptor signaling |
|
16 |
Gap junction |
34 |
VEGF signaling |
|
17 |
GnRH signaling |
35 |
Wnt signaling |
|
18 |
Hematopoietic cell lineage |
||
|
|
|||
|
1 Pathway description |
|||
|
Altomare et al. BMC Cancer 2010 10:34 doi:10.1186/1471-2407-10-34 |
|||
